Novartis news - Livemint
Livemint
epaper
×
Home Companies Money Industry Technology Politics Opinion LoungeMultimediaAI Science Education Sports ConsumerSpecials
×
Home » Novartis

Search Results for Novartis »

News Videos Slideshows
Almost 50% of breast cancer patients first visit the doctor when they are in stage 3 and 15-20% of patients visit when they are in stage 4, the researchers said.

Thu, Oct 25 2018. 11 04 PM IST

Young Indian women are more vulnerable to breast cancer, says CII report

The incidence of breast cancer is 25.8 per 100,000 women and is expected to rise to 35 per 100,000 women in 2026, says health ministry

Endocyte makes radioactive drugs coupled with targeting molecules to deliver treatments to tumors. Photo: Pradeep Gaur/Mint

Thu, Oct 18 2018. 04 20 PM IST

Novartis targets prostate cancer with $2.1 billion Endocyte deal

Novartis will pay $24 a share for Endocyte, 54% more than its closing price Wednesday of $15.56

Photo: iStock

Tue, Sep 25 2018. 11 10 PM IST

Make it large—a significant trend in the Indian pharmaceutical industry

The spike in deal activity could be attributed to Aurobindo Pharma’s agreement to buy units of Sandoz for $1 billion

The main asset on the block is GSK’s 72.5% stake in its Indian subsidiary GlaxoSmithKline Consumer Healthcare, which is famous for Horlicks but also makes products including the chocolate-flavoured malt-based drink Boost. Photo: Mint

Tue, Sep 18 2018. 10 17 PM IST

Nestle, Unilever, Coke make bids in $4 billion-plus GSK India sale: report

Nestle, Unilever and Coca-Cola are among bidders for GlaxoSmithKline’s Indian Horlicks nutrition business, expected to fetch more than $4 billion

Illustration: Jayachandran/Mint

Tue, Sep 18 2018. 10 48 AM IST

India Inc. wants your shares

Indian companies are queuing up to return capital to shareholders by way of share buybacks. For now, investors aren’t complaining

Ola founders Bhavish Aggarwal and Ankit Bhati won the backing of Temasek that has agreed to vote with them as a part of a recently structured secondary subscription of shares. Photo: Mint

Fri, Sep 07 2018. 05 16 PM IST

Deals Buzz: Ola founders get Temasek vote for secondary share purchase

In other news, L&T Technology Services will buy Graphene Semiconductor Services for Rs 93 crore in an all cash deal, and Aurobindo Pharma has agreed to buy the dermatology business and three manufacturing units of Sandoz

BSE Sensex and NSE’s Nifty 50 closed higher on Friday. Photo: Reuters

Fri, Sep 07 2018. 09 04 AM IST

Closing bell: Sensex gains 147 points, Nifty settles at 11589, auto stocks rally

BSE Sensex closed 147.01 points up at 38,389.82, while the Nifty 50 ended 52.20 points higher at 11,589.10. Here are the highlights from the markets

Aurobindo Pharma Ltd is paying up to $1 billion (Rs 7,200 crore) to acquire a slice of the generics business of Sandoz, a division of Novartis AG. Graphic: Mint

Thu, Sep 06 2018. 03 19 PM IST

In Aurobindo Pharma’s US acquisition, beauty runs skin deep

Aurobindo is acquiring the dermatology business which contributes to 30% of the acquired business’s revenues, with the remaining contributed by the oral solids business

Aurobindo will finance the deal through a fully committed debt facility. The acquired business had sales of $1.2 billion in 2017. Photo: Bloomberg

Thu, Sep 06 2018. 09 53 AM IST

Aurobindo agrees to acquire Novartis’s US generics business for $1 billion

An initial $900 million cash payment to the Basel-based Novartis could be followed by $100 million in performance-based payments

BSE Sensex and NSE’s Nifty 50 traded higher on Thursday. Photo: Mint

Thu, Sep 06 2018. 08 55 AM IST

Closing bell: Sensex, Nifty snap six-day losing streak

BSE Sensex closed 224.50 points up at 38,242.81, while the Nifty 50 ends 59.95 points higher at 11,536.90. Here are the highlights from the markets

12345Next »